Can Topical CBD Oil Show Up On Drug Test

CBDISTILLERY

Buy CBD Oil Online

Testing positive using CBD in massage services has been a concern among massage therapists and clients alike. Will these sevices lead to a failed drug test? Can a THC/CBD Topical Cause You to Fail a Drug Test? When we think of typical cannabis use, we think of smoking a bowl, bong, blunt or joint. Some stoners may also use concentrates such as resin, A male driver was checked during a traffic stop. A blood sample was collected 35min later and contained 7.3ng/mL THC, 3.5ng/mL 11-hydroxy-THC and 44.6ng/mL 11-nor-9-carboxy-THC. The subject claimed to have used two commercially produced products topically that contained 1.7ng and 102ng THC per mg, r …

Will Topical CBD Products Cause Massage Clients to Fail a Drug Test?

Are you finding some important questions unanswered with the growing service and product offering of CBD products?

The safety of using CBD products is high on clients’ list of concerns — with the most important question posed to the practitioner being, “Will this show up on a drug test?”

There are areas of misunderstanding, curiosity and confusion surrounding CBD use, especially due to the marijuana branding over the last four decades and marijuana’s legal status. (For more information, read “The MT’s Guide to Marijuana and Massage.”)

Let’s dive into this issue so you know how to respond to clients’ questions.

A CBD Review

CBD, or cannabidiols, are a class of compounds from the cannabis plant called cannabinoids.

The cannabis plant contains more than 400 compounds, and 60 plus are cannabinoid and include terpenes similar to those in essential oils, like limonene, pinene, myrcene and linalool. The compound mix in cannabis products is dependent upon the extraction method used, which may be a supercritical carbon dioxide (CO2) extract, a distillate or compound isolating technique.

The two important compounds to discuss, both cannabinoids, are cannabidiol and delta-9-tetrahydrocannabinol (THC).

Cannabidiol is the non-psychoactive compound desired for medical use, pain and inflammation. The compound associated with the intoxicating effect is THC.

A differentiation is made regarding the plant used for extraction. Hemp has 0.3% or less THC content, where marijuana has the psychoactive content of 15-45%. Both are from the botanical species Cannabis sativa.

The safety of CBD use is still being established. There are some individuals who may have such slight side-effects as digestive issues, tiredness, dizziness or changes in weight and appetite. These side-effects are documented for internal use of CBD. Topical application of CBD is not sensitizing and, except in rare cases, would not have the side-effects noted for internal use.

Safety and sensitivity in topical solution, due to the other ingredients in the formula, would then be determined as would any other topical sold or used.

Legal in the U.S?

CBD products are legal in all 50 states — or not. This is a grey area. When doing the research the overall consensus is that it is legal. Conditions arise when looking at state level laws or conditions. (Note: this article is not meant as legal advice; contact your regulating board or legal counsel in your geographic area to determine if use of CBD products is legal where you live.)

The difference between legal and illegal may be determined from the source of the CBD, meaning whether derived from marijuana or hemp.

The 2014 Farm Bill made hemp legal in all 50 states, and so making hemp-derived CBD legal in all 50 states. Still, some states do not fully embrace these federal laws. Again, it’s recommended that you check the legal status in your state before using CBD products or offering services.

See also  Green Roads CBD Oil For Dogs

Internationally. CBD laws vary and, like in the U.S, acquiring thorough guidelines on its use will be vitally important. (For more information, read “Marijuana & Massage: Are CBD Pain-Relief Products Caught up in New DEA Rule?”)

There is a legal limit of 0.3% on THC content within a CBD product. This is a very low, non-psychoactive level and why hemp, already low in THC, is an often-desired source of CBD. It should be noted that even the low-level THC content, as well as a mix of other cannabinoids, is thought to assist in CBD efficacy.

The product manufacturer should have documentation of content in the extracts used.

Drug Testing

Over the past decades, employers have been administering mandatory drug testing, especially in government, health care and transportation — trucking, bussing and airlines — industries. Until the recent influx of CBD products and services, this wasn’t an issue of concern to the massage or spa therapist.

There are four testing methods used; blood, hair, saliva and urine analysis.

Drug testing for marijuana use is determined by the appearance of THC metabolites, not CBD. With a 0.3% limit of THC in the extract, the question remains as to whether this amount, or less considering the extract is further diluted in the whole formula, can accumulate in the body or in other ways show up as THC metabolites in drug testing.

“Will I Fail My Drug Test?”

Failing a drug test after receiving a massage service involving a CBD topical product is not likely, according to most experts in research of topical CBD products. Consider:

• To fail a drug test, the Substance Abuse and Mental Health Services Administration guideline has a detection limit for the presence of THC, distinguished as a specific metabolite of THC, as 50 ng/mL.

• One estimate puts the threat of failing from an internal, not topical, dose of 1,000 mg and legal THC limit of 0.3% or less, at 23%.

• Another source declared a 1,000-2,000 mg dose, orally, gives an 11-23% chance of drug test detection.

• Key factors, beyond dosage, are the amount of THC contained in the extract, accurate labeling, metabolism, body mass and delivery method. If the extract is hemp-derived, it’s been determined there is no chance of detection.

• A CBD isolate, a product either specifically extracted or filtered to contain only the cannabidiol compound, if not contaminated in any way with THC, has no detection in drug tests.

Topical Application and Skin Absorption

With topical application it is highly unlikely, and close to impossible, for an amount of THC to be absorbed and metabolized by the body and detected in a drug test. Of course, there are circumstances that could change this such as the use of penetration enhancers, transdermal patches, and a higher than legal limit of THC in the product.

Topical CBD products are used for pain, inflammation and skin conditioning where the cannabidiols function by way of receptors in the cutaneous layers of the skin. Penetration into the blood is not necessary for localized therapeutic effect. The skin is designed to keep things out, making it logical that studies using blood and urine sampling find no penetration of cannabinoids following application.

The Jury is Still Out

Although evidence shows it would be unlikely to fail a drug test from topical use of CBD products, unease will continue for those who are drug tested at work. If employment is dependent on a clean reading, it is reasonable to accept clients’ hesitation or resistance to CBD use or services.

See also  CBD Gummies And Metoprolol

Precautionary measures may suggest introducing the conversation and alerting guests to CBD use and drug-testing.

As the market for CBD products grow, potential changes in drug testing may follow. For now, this will remain a challenging situation for all affected by employee drug testing.

Jimm Harrison is an internationally recognized essential oil and botanical skin care consultant, educator and author. He has developed botanical skin care, custom essential oil formulations and scent branding for spas and the retail health care industry. He is the author of Aromatherapy: Therapeutic Use of Essential Oils for Skin and Health and Easy Essential Oil Chemistry. Hedeveloped and teaches the Essential Oil and Aromatherapy Certificate Program at Bastyr University School of Natural Medicine, Kenmore, Washington. His article for MASSAGE Magazine include “Best Application Methods for Essential Oils.”

Related Posts

At a Glance Topical products derived from cannabis are used by many people to effect…

Sponsored by Massage Study Buddy Marijuana is big news—and big money. Many states have passed…

One way to get more vacationers into your massage practice is to promote your cannabidiol…

Regardless of the reason for your clients’ visit, the products you use in your sessions…

The American Massage Therapy Association’s (AMTA) 2011 National Massage Therapy Awareness Week is Oct. 23–29.…

California’s massage therapists may participate in a beta-test of the new application for certification and…

Can a THC/CBD Topical Cause You to Fail a Drug Test?

When we think of typical cannabis use, we think of smoking a bowl, bong, blunt or joint. Some stoners may also use concentrates such as resin, live budder, water hash, etc. Nowadays, we can also enjoy our cannabis in a plethora of candies, cookies, cakes, and even infused olive oils. Finally, with the arrival of CBD on the scene, products have evolved to include topical cannabis items like body creams, salves, lotions, balms. As the industry continues to change and grow to include new ways to incorporate the cannabis plant, we need to wonder: which of these fascinating new things will get us high and/or, which would show up on a drug test?

It’s (fairly) common knowledge that the consumption of marijuana can be detected on a drug test because it ends up in various parts of the body, showing up in urine, blood and even hair follicles. Cannabis is typically consumed orally (smoke, vapor, candy, etc.), which is why it can be found in these tests. So, what happens when we use cannabis in a different way? In other words, if you’re using THC/CBD cream, lotion, salves, balms, etc. are you on the road to a failed drug test and potential lost job opportunity?

The short answer is no. When using topical marijuana products, remember that your skin acts as a barrier between the outside world and the inner workings of your system. Although there is THC, CBD or other cannabinoids in the lotion/cream which is absorbed into your skin, muscles and nerves, it does not reach your bloodstream (and ultimately, your brain, where the psychoactive aspect of THC is caused), so it cannot be detected by a test. Since you’re not consuming the THC orally, there’s no way for it to get into your bloodstream.

The one caution/exception to the topical rule is transdermal patches. These work similarly to nicotine patches, and send the THC/CBD past the skin barrier where it can reach your bloodstream and your brain so you also experience the psychoactive effects. This WILL result in a failed drug test should you take one.

See also  Northern Sense CBD Oil

In the end think of topicals the same way you would think of alcohol. The only way you can increase your BAC (blood-alcohol content) is by drinking (you can’t get drunk by rubbing Grey Goose on your thigh!). The same holds true with marijuana. The only way you can put THC/CBD into your bloodstream is by oral consumption or a specific transdermal patch. So, assuming you use only topical cannabis and you’re not into smoking, vaping, or edibles, you’re set to go take your drug test and pass with flying colors! If you enjoy oral consumption, too, we might suggest holding off on the other categories before heading in for your test.

By riverrockco | 2020-11-11T14:17:31-07:00 May 13th, 2020 | Lifestyle | Comments Off on Can a THC/CBD Topical Cause You to Fail a Drug Test?

Topical application of THC containing products is not able to cause positive cannabinoid finding in blood or urine

A male driver was checked during a traffic stop. A blood sample was collected 35min later and contained 7.3ng/mL THC, 3.5ng/mL 11-hydroxy-THC and 44.6ng/mL 11-nor-9-carboxy-THC. The subject claimed to have used two commercially produced products topically that contained 1.7ng and 102ng THC per mg, respectively. In an experiment, three volunteers (25, 26 and 34 years) applied both types of salves over a period of 3days every 2-4h. The application was extensive (50-100cm 2 ). Each volunteer applied the products to different parts of the body (neck, arm/leg and trunk, respectively). After the first application blood and urine samples of the participants were taken every 2-4h until 15h after the last application (overall n=10 urine and n=10 blood samples, respectively, for each participant). All of these blood and urine samples were tested negative for THC, 11-hydroxy-THC and 11-nor-9-carboxy-THC by a GC-MS method (LoD (THC)=0.40ng/mL; LoD (11-hydroxy-THC)=0.28ng/mL; LoD (THC-COOH)=1.6ng/mL;. LoD (THC-COOH in urine)=1.2ng/mL). According to our studies and further literature research on in vitro testing of transdermal uptake of THC, the exclusive application of (these two) topically applied products did not produce cannabinoid findings in blood or urine.

Keywords: Cannabinoids; Gaschromatography mass spectrometry; Hemp oil containing cremes; Topic.

Copyright © 2017 Elsevier Ireland Ltd. All rights reserved.

Similar articles

Mieczkowski T. Mieczkowski T. Forensic Sci Int. 1995 Jan 5;70(1-3):83-91. doi: 10.1016/0379-0738(94)01628-i. Forensic Sci Int. 1995. PMID: 7860039

Fraser AD, Worth D. Fraser AD, et al. Forensic Sci Int. 2004 Jul 16;143(2-3):147-52. doi: 10.1016/j.forsciint.2004.02.034. Forensic Sci Int. 2004. PMID: 15240035

Meier U, Dussy F, Scheurer E, Mercer-Chalmers-Bender K, Hangartner S. Meier U, et al. Forensic Sci Int. 2018 Oct;291:62-67. doi: 10.1016/j.forsciint.2018.08.009. Epub 2018 Aug 11. Forensic Sci Int. 2018. PMID: 30149280

Teixeira H, Verstraete A, Proença P, Corte-Real F, Monsanto P, Vieira DN. Teixeira H, et al. Forensic Sci Int. 2007 Aug 6;170(2-3):148-55. doi: 10.1016/j.forsciint.2007.03.026. Epub 2007 Jul 5. Forensic Sci Int. 2007. PMID: 17614225

Uhl M, Sachs H. Uhl M, et al. Forensic Sci Int. 2004 Oct 29;145(2-3):143-7. doi: 10.1016/j.forsciint.2004.04.029. Forensic Sci Int. 2004. PMID: 15451086

Cited by

Mahmoudinoodezh H, Telukutla SR, Bhangu SK, Bachari A, Cavalieri F, Mantri N. Mahmoudinoodezh H, et al. Pharmaceutics. 2022 Feb 18;14(2):438. doi: 10.3390/pharmaceutics14020438. Pharmaceutics. 2022. PMID: 35214170 Free PMC article. Review.

How useful was this post?

Click on a star to rate it!

Average rating 5 / 5. Vote count: 1

No votes so far! Be the first to rate this post.